An institutional investor just invested $9M in this stock, he wouldn't invest here if R/S. We're safe here. A mkt cap of $40M is laughable, should be $400M by now. I bet they make around $5-$10 per test kit. They also got CE mark, so the test kits can be used in Europe & other continents, but not in US yet. Still, lot of countries need this rapid test kits now.
I think this opportunity will boost the company going forward.
$10